KPTI Dividend History & Analysis | N/A Yield
KPTI has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,657 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,397 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,657 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
KPTI Dividend History: as of February 2026
No dividends paid yet.KPTI Dividend FAQ
Karyopharm Therapeutics (NASDAQ: KPTI) is a commercial-stage biotech that develops small-molecule Selective Inhibitors of Nuclear Export (SINE) targeting exportin-1 (XPO1). Its flagship product, XPOVIO (selinexor), is approved in the U.S. for multiple myeloma (in combination with bortezomib + dexamethasone or dexamethasone alone) and for relapsed/refractory diffuse large B-cell lymphoma (DLBCL). The pipeline also includes selinexor for other hematologic and solid tumors, ELTANEXOR for myelodysplastic neoplasms, and early-stage assets such as verdinexor, KPT-9274, and IL-12-based therapies.
What is the Dividend Yield of KPTI?
As of February 2026, KPTI`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 6.26.Does KPTI pay a dividend?
As of February 2026 KPTI does not pay a dividend.How often does KPTI pay dividends?
Over the last 12 months, KPTI has issued dividend payments.KPTI dividend forecast
Based on historical data, the forecasted dividends per share for KPTI for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will KPTI pay dividends in 2026?
The next Ex-Dividend date for Karyopharm Therapeutics (KPTI) is currently unknown.What is the next Ex-Dividend Date for KPTI?
The next Ex-Dividend date for Karyopharm Therapeutics (KPTI) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of KPTI?
KPTI's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of KPTI?
KPTI's 5-Year Yield on Cost is -%. If you bought KPTI's shares at 243.60 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of KPTI?
KPTI Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does KPTI have a good Dividend Yield?
KPTI`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of KPTI?
The Dividend Payout Ratio of KPTI is unknown.What is the Dividend Rating of KPTI?
KPTI`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-09 02:18